CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.

類似資料

• Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.
  著者:: Patick, A K, 等
  出版事項: (1996)
• Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.
  著者:: Reich, S H, 等
  出版事項: (1995)
• Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
  著者:: Lamarre, D, 等
  出版事項: (1997)
• ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
  著者:: Kempf, D J, 等
  出版事項: (1995)
• Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier
  著者:: Dierynck, Inge, 等
  出版事項: (2007)